Like agricultural pesticides, vector control insecticides are developed mostly in the private sector by large diversified chemical companies. The cost of developing, testing, and registering a new active ingredient for vector control is quite high—over $175 million by one estimate.
That’s why companies typically spin off vector control products from existing agricultural products and why they sell products using the same active ingredients in both markets. Of course, the final products themselves are not identical; as Lines explains, agricultural insecticides may contain solvents and other ingredients that would not be safe in a public health product.The cost factor is also why staff in vector control divisions cannot always take actions that make sense from a resistance management perspective. Vector control insecticides are vastly less profitable than agrochemicals, with the former bringing in about $1 billion per year globally compared with $50 billion for the latter.
“We as the ‘little stepbrother’ cannot say to our big brother, ‘Okay, take this active ingredient from the [agriculture] market because we are now finding that it has good efficacy against vectors,’” says Gerhard Hesse, the recently retired global partnering manager for vector control at Bayer, which is a leading producer of agrochemicals.Some vector control chemicals end up being taken off the market for economic reasons. According to Dan Strickman, a senior program officer in vector control at the Bill and Melinda Gates Foundation, that is what happened with resmethrin and allethrin, two pyrethroids used in mosquito control. “There have been several chemicals like that,” he says. “It’s not that they were not useful; they were extremely useful for vector control. But there just weren’t enough sales to support the studies required to ensure their safety.”The likelihood of companies developing new classes of chemicals solely for vector control is similarly low. But recently, an initiative has emerged to help them do so. It is called the Innovative Vector Control Consortium, or IVCC, and some experts say it is the world’s best chance at a chemical solution to insecticide resistance.IVCC is a public–private partnership established in 2005 by Janet Hemingway, the director of the Liverpool School of Tropical Medicine, to develop new vector control tools. An eminent vector control biologist, Hemingway foresaw the current wave of pyrethroid resistance before many others.
She also recognized that industry was not solving the problem on its own. New products were not coming down the pipeline quickly enough, and they were not being managed correctly once they were on the market. So she decided to bring together chemical companies, academics, and funders in a product development partnership similar to those that exist for pharmaceutical drugs.Armed with an initial grant of $50 million from the Bill and Melinda Gates Foundation and funding from the UK’s Department for International Development, the U.S. Agency for International Development, and the Swiss Agency for Development and Cooperation, IVCC convinced industry giants like Bayer, Sygenta, Sumitomo, and BASF to comb their chemical libraries for molecules that might be developed into insecticides to fight malaria vectors. These companies have so far narrowed a field of 4.5 million chemical candidates to just nine; the ultimate goal is to develop three new active ingredients that can be brought to market by 2022.The purpose of this effort is to develop novel compounds that would kill mosquitoes in entirely new ways, so in theory they likely would be unaffected by the resistance mechanisms that already exist in wild populations. The hope is that their efficacy could be maintained until malaria is eradicated—provided they were deployed with extreme care in both public health and agriculture.Nick Hamon, IVCC’s current CEO, says the consortium is unlikely to demand that new active ingredients be kept out of agriculture altogether, in part for financial reasons (the narrower the potential market for new chemicals, the more IVCC must contribute to companies to help develop them). Instead, he is negotiating agreements that would limit where and how companies are allowed to market them in agriculture. “We will encourage these companies to stay out of malaria-endemic countries for a certain number of years,” he says.John Lucas, a senior business development manager at Sumitomo, is sympathetic to that demand. “I think [IVCC has] every right to say they want to try to preserve the efficacy of these chemistries, so let’s make sure they’re not used heavily in ag and other areas,” he says.Despite such accommodations, Hamon remains keenly aware of the economic realities driving the corporations he partners with. “I worry every day about these companies saying ‘we’ve had enough,’” he says. He estimates that in the past 20 years, the number of companies capable of doing basic research on novel vector control insecticides has fallen from over 15 to only five or six, as companies have bought up one another, reducing the options IVCC has for partnering. “They’ve got bigger fish to fry than us,” he says. “And so we are very dependent on their goodwill.”The issue may be moot; according to Hamon, most of the nine chemicals IVCC is currently examining in detail do not look very promising for use against agricultural pests. “It’s great because now you’ve got some tools that are ‘owned’ by public health, but on the other hand the markets are very, very small, so we have to spend a lot more time finding people who want to fund [the development work],” he says. That’s because a smaller potential market for the chemicals makes companies less willing to pour their own resources into developing them.In the meantime, the partnership is also repurposing a number of existing agricultural insecticides for use in vector control. But Hamon says this is a temporary strategy “because they are out there in agriculture, and in some cases there may already be resistance.”
Beyond Insecticides
On a hot, clear morning, entomologist Etienne Bilgo sits in the back seat of a car headed toward an IRSS research site in Soumouso, Burkina Faso, where he is attempting to circumvent dependence on chemicals altogether.“We have to take a little pressure off the insecticides,” says Bilgo, a 29-year-old PhD student under Diabaté. Outside, a green savannah dotted with mango, baobab, and neem trees scrolls by, interrupted here and there by the fields of cotton that have played such a central role in creating that pressure. “We have to find complementary tools. That could be medicine, or hygiene, or reducing breeding sites.”Tools like these have been crucial in eliminating malaria from wealthier countries around the world. But measures such as draining irrigation ditches, clearing vegetation around houses, and putting screens on windows and eaves must be carefully tailored to each location, and they don’t work everywhere.
Climate change is further complicating the picture by reshuffling the areas in which vectors can thrive.In Soumouso, Bilgo and Diabaté are preparing to test something different: a transgenic fungus designed by scientists at the University of Maryland, which expresses a toxin produced by scorpions. The fungus, sprayed on mosquitoes, invades the insects’ blood stream and attacks malaria parasites so they cannot be transmitted to people.
,
“The best thing about the fungi is they don’t kill the mosquitoes quickly, so they have time to reproduce, and they stay susceptible for many generations,” says Bilgo.Stepping out of the car, he heads toward a large, low greenhouse-like building whose walls and roof are made of netting. Inside is a replica of a village street, with small mud huts, gardens, and an enclosure full of sleepy cows. Soon, Bilgo will release mosquitoes inside and begin testing the less potent non-transgenic version of the fungus on them as a precursor to importing the transgenic version for tests.Elsewhere around the world, scientists are working on other new tools to fight malaria, like vaccines
and genetically modified sterile or disease-resistant mosquitoes.
Many are promising. But Strickman, the Gates Foundation program officer, says none provides an immediate escape hatch from the resistance dilemma.“In the next 20 years, it’s hard to imagine a solution [to malaria] that doesn’t involve insecticides,” he says. Until that solution is found, the actions of farmers, and of the agrochemical companies that supply them with pesticides, will continue to matter greatly in the fight against malaria.
Authors: Abdoulaye Diabate; Thierry Baldet; Fabrice Chandre; Martin Akoobeto; T Robert Guiguemde; Frédéric Darriet; Cécile Brengues; Pierre Guillet; Janet Hemingway; Graham J Small; Jean Marc Hougard Journal: Am J Trop Med Hyg Date: 2002-12 Impact factor: 2.345
Authors: Justin M Cohen; David L Smith; Chris Cotter; Abigail Ward; Gavin Yamey; Oliver J Sabot; Bruno Moonen Journal: Malar J Date: 2012-04-24 Impact factor: 2.979
Authors: Maike Tipke; Valérie R Louis; Maurice Yé; Manuela De Allegri; Claudia Beiersmann; Ali Sié; Olaf Mueller; Albrecht Jahn Journal: Malar J Date: 2009-11-24 Impact factor: 2.979
Authors: Theresia E Nkya; Idir Akhouayri; Rodolphe Poupardin; Bernard Batengana; Franklin Mosha; Stephen Magesa; William Kisinza; Jean-Philippe David Journal: Malar J Date: 2014-01-25 Impact factor: 2.979
Authors: Richard E Cibulskis; Pedro Alonso; John Aponte; Maru Aregawi; Amy Barrette; Laurent Bergeron; Cristin A Fergus; Tessa Knox; Michael Lynch; Edith Patouillard; Silvia Schwarte; Saira Stewart; Ryan Williams Journal: Infect Dis Poverty Date: 2016-06-09 Impact factor: 4.520